{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:55:33Z","timestamp":1718949333757},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T00:00:00Z","timestamp":1401408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Incl Phenom Macrocycl Chem"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10847-014-0416-4","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T20:38:37Z","timestamp":1408480717000},"page":"125-132","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Obtention and characterization of a ciclesonide: methyl-beta cyclodextrin complex"],"prefix":"10.1007","volume":"80","author":[{"given":"Nuno","family":"Arriagas","sequence":"first","affiliation":[]},{"given":"Helena","family":"Cabral-Marques","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,5,30]]},"reference":[{"key":"416_CR1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/TCRM.S5433","volume":"7","author":"E Singas","year":"2011","unstructured":"Singas, E., Karpel, J.P.: Profile of ciclesonide for the maintenance treatment of asthma. Ther. Clin. Risk Manag. 7, 351\u2013358 (2011). doi: 10.2147\/TCRM.S5433","journal-title":"Ther. Clin. Risk Manag."},{"key":"416_CR2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMra0804579","volume":"360","author":"CH Fanta","year":"2009","unstructured":"Fanta, C.H.: Asthma. N. Engl. J. Med. 360, 1002\u20131014 (2009). doi: 10.1056\/NEJMra0804579","journal-title":"N. Engl. J. Med."},{"key":"416_CR3","unstructured":"INFARMED, I.P.: Resumo das Caracter\u00edsticas do Medicamento\u2014Alvesco 160 microgramas\/dose, Solu\u00e7\u00e3o pressurizada para inala\u00e7\u00e3o. http:\/\/www.infarmed.pt\/infomed\/detalhes.php?med_id=44299&dci=&nome_comer=YWx2ZXNjbw==&dosagem=&forma_farmac=&atc=&estado_aim=&pesquisa_titular=&pagina=1 (2012). Accessed 13 March 2012"},{"key":"416_CR4","unstructured":"Food and Drugs Administration: Ciclesonide Omnaris. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/PediatricAdvisoryCommittee\/UCM166822.pdf (2012). Accessed 2 Feb 2012"},{"key":"416_CR5","unstructured":"Food and Drugs Administration: Ciclesonide: Clinical Pharmacology Review. http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/ucm071869.pdf (2012). Accessed 20 Feb 2012"},{"key":"416_CR6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pupt.2011.04.002","volume":"24","author":"P Ratner","year":"2011","unstructured":"Ratner, P., Wingertzahn, M.A., Herzog, R., Huang, H., Desai, S.Y., Maier, G., et al.: An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis. Pulm. Pharmacol. Ther. 24, 426\u2013433 (2011). doi: 10.1016\/j.pupt.2011.04.002","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"416_CR7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1513\/pats.200403-025MS","volume":"1","author":"J Winkler","year":"2004","unstructured":"Winkler, J., Hochhaus, G., Derendorf, H.: How the lung handles drugs. Proc Am Thorac Soc 1(4), 356\u2013363 (2004)","journal-title":"Proc Am Thorac Soc"},{"key":"416_CR8","author":"M Silvestri","year":"2011","unstructured":"Silvestri, M., Morandi, F., Pistoia, V., Prigione, I., Rossi, G.A.: Ciclesonide modulates in vitro allergen-driven activation of blood mononuclear cells andallergen-specific T-cellblasts. Immunol. Lett. (2011). doi: 10.1016\/j.imlet.2011.10.003","journal-title":"Immunol. Lett."},{"key":"416_CR9","unstructured":"Drugs.com: Omnaris FDA Approval History. http:\/\/www.drugs.com\/history\/omnaris.html (2012). Accessed 21 Feb 2012"},{"key":"416_CR10","unstructured":"Drugs.com: Omnaris Altana Pharma\u2014Treatment for Allergic Rhinitis. http:\/\/www.drugs.com\/newdrugs\/omnaris-altana-pharma-allergic-rhinitis-16.html (2012). Accessed 21 Feb 2012"},{"key":"416_CR11","unstructured":"Drugs.com: Zetonna FDA Approval History. http:\/\/www.drugs.com\/history\/zetonna.html (2012). Accessed 21 Feb 2012"},{"key":"416_CR12","unstructured":"Drugs.com: FDA Approves Zetonna (ciclesonide) Nasal Aerosol for Allergic Rhinitis. http:\/\/www.drugs.com\/newdrugs\/fda-approves-zetonna-ciclesonide-nasal-aerosol-allergic-rhinitis-3046.html (2012). Accessed 21 Feb 2012"},{"key":"416_CR13","volume-title":"Respiratory Drug Delivery: Essential Theory and Practice","author":"S Newman","year":"2009","unstructured":"Newman, S.: Respiratory Drug Delivery: Essential Theory and Practice. Davis Healthcare International Publishing, Moore (2009)"},{"key":"416_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.addr.2010.11.004","volume":"63","author":"B Forbes","year":"2011","unstructured":"Forbes, B., Asgharian, B., Dailey, L.A., Ferguson, D., Gerde, P., Gumbleton, M., et al.: Challenges in inhaled product development and opportunities for open innovation. Adv. Drug Deliv. Rev. 63, 69\u201387 (2011). doi: 10.1016\/j.addr.2010.11.004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"416_CR15","volume-title":"Inhalation Aerosols","author":"AJ Hickey","year":"2007","unstructured":"Hickey, A.J.: Inhalation Aerosols. Informa Healthcare, New York (2007)"},{"key":"416_CR16","author":"JS Patton","year":"2010","unstructured":"Patton, J.S., Brain, J.D., Davies, L.A., Fiegel, J., Gumbleton, M., Kim, K.J., et al.: The particle has landed\u2014characterizing the fate of inhaled pharmaceuticals. J. Aerosol. Med. Pulm. Drug Deliv. (2010). doi: 10.1089\/jamp.2010.0836","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"issue":"6","key":"416_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1742-7843.2006.pto_355.x","volume":"98","author":"S Edsb\u00e4cker","year":"2006","unstructured":"Edsb\u00e4cker, S., Johansson, C.-J.: Airway selectivity: an update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids. Basic Clin. Pharmacol. Toxicol. 98(6), 523\u2013536 (2006)","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"10","key":"416_CR18","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1183\/09031936.97.10102194","volume":"10","author":"JG Widdicombe","year":"1997","unstructured":"Widdicombe, J.G.: Airway liquid: a barrier to drug diffusion? Eur. Respir. J. 10(10), 2194\u20132197 (1997)","journal-title":"Eur. Respir. J."},{"issue":"4","key":"416_CR19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","volume":"1","author":"JS Patton","year":"2004","unstructured":"Patton, J.S., Fishburn, C.S., Weers, J.G.: The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1(4), 338\u2013344 (2004)","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"2","key":"416_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09031936.03.00018202","volume":"22","author":"H Fukaya","year":"2003","unstructured":"Fukaya, H., Iimura, A., Hoshiko, K., Fuyumuro, T., Noji, S., Nabeshima, T.: A cyclosporin A\/maltosyl-\u03b1-cyclodextrin complex for inhalation therapy of asthma. Eur. Respir. J. 22(2), 213\u2013219 (2003)","journal-title":"Eur. Respir. J."},{"key":"416_CR21","author":"HMC Marques","year":"2010","unstructured":"Marques, H.M.C.: A review on cyclodextrin encapsulation of essential oils and volatiles. Flavour Frag J. (2010). doi: 10.1002\/ffj.2019","journal-title":"Flavour Frag J."},{"issue":"9","key":"416_CR22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","volume":"39","author":"ED Valle","year":"2004","unstructured":"Valle, E.D.: Cyclodextrins and their uses: a review. Process Biochem. 39(9), 1033\u20131046 (2004)","journal-title":"Process Biochem."},{"key":"416_CR23","author":"CR Dass","year":"2000","unstructured":"Dass, C.R., Jessup, W.: Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review. J. Pharm. Pharmacol. (2000). doi: 10.1211\/0022357001774606","journal-title":"J. Pharm. Pharmacol."},{"key":"416_CR24","author":"J Szejtli","year":"1998","unstructured":"Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. (1998). doi: 10.1021\/cr970022c","journal-title":"Chem. Rev."},{"key":"416_CR25","unstructured":"Roquette Pharma: Visionneuse. http:\/\/www.roquette-pharma.com\/brochures\/03\/visio.html (2012). Accessed 26 Feb 2012"},{"key":"416_CR26","author":"G Piel","year":"2007","unstructured":"Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., Delattre, L.: Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. J. Incl. Phenom. Macrocycl. Chem. (2007). doi: 10.1007\/s10847-006-9178-y","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"416_CR27","author":"T Kiss","year":"2010","unstructured":"Kiss, T., Fenyvesi, F., B\u00e1cskay, I., V\u00e1radi, J., Fenyvesi, \u00c9., Iv\u00e1nyi, R., et al.: Evaluation of the cytotoxicity of [beta]-cyclodextrin derivatives: evidence for the role of cholesterol extraction. Eur. J. Pharm. Sci. (2010). doi: 10.1016\/j.ejps.2010.04.014","journal-title":"Eur. J. Pharm. Sci."},{"key":"416_CR28","author":"L Salem","year":"2009","unstructured":"Salem, L., Bosquillon, C., Dailey, L., Delattre, L., Martin, G., Evrard, B., et al.: Sparing methylation of \u03b2-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. J Control Release (2009). doi: 10.1016\/j.jconrel.2009.01.019","journal-title":"J Control Release"},{"key":"416_CR29","author":"N Islam","year":"2012","unstructured":"Islam, N., Cleary, M.J.: Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery\u2014a review for multidisciplinary researchers. Med. Eng. Phys. (2012). doi: 10.1016\/j.medengphy.2011.12.025","journal-title":"Med. Eng. Phys."},{"key":"416_CR30","author":"G Pilcer","year":"2010","unstructured":"Pilcer, G., Amighi, K.: Formulation strategy and use of excipients in pulmonary drug delivery. Int. J. Pharm. (2010). doi: 10.1016\/j.ijpharm.2010.03.017","journal-title":"Int. J. Pharm."},{"key":"416_CR31","author":"H Cabral-Marques","year":"2009","unstructured":"Cabral-Marques, H., Almeida, R.: Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid\/cyclodextrin inclusion complexes. Eur. J. Pharm. Biopharm. (2009). doi: 10.1016\/j.ejpb.2009.05.002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"416_CR32","first-page":"117","volume":"4","author":"T Higuchi","year":"1965","unstructured":"Higuchi, T., Connors, K.: Phase solubility techniques. Adv. Anal. Chem. Instrum. 4, 117\u2013212 (1965)","journal-title":"Adv. Anal. Chem. Instrum."},{"key":"416_CR33","author":"Y Cheng","year":"1993","unstructured":"Cheng, Y., Barr, E., Marshall, I., Mitchell, J.: Calibration and performance of an API aerosizer. J. Aerosol Sci. (1993). doi: 10.1016\/0021-8502(93)90034-7","journal-title":"J. Aerosol Sci."},{"key":"416_CR34","unstructured":"European Pharmacopoeia, Directorate for the Quality of Medicines of the Council of Europe, Strasbourg (2011)"},{"issue":"57","key":"416_CR35","first-page":"546","volume":"8","author":"HMC Marques","year":"2002","unstructured":"Marques, H.M.C., Schmidt, P.C.: In vitro deposition of the respirable fraction of dry powder inhalations determined by laser diffractometry and inertial impaction. Pharmazie 8(57), 546\u2013551 (2002)","journal-title":"Pharmazie"},{"key":"416_CR36","author":"P Sal\u00fastio","year":"2009","unstructured":"Sal\u00fastio, P., Feio, G., Figueirinhas, J., Pinto, J., Cabral, H.M.: The influence of the preparation methods on the inclusion of model drugs in a [beta]-cyclodextrin cavity. Eur. J. Pharm. Biopharm. (2009). doi: 10.1016\/j.ejpb.2008.09.027","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"416_CR37","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1002\/jps.21223","volume":"97","author":"MP Feth","year":"2008","unstructured":"Feth, M.P., Volz, J., Hess, U., Sturm, E., Hummel, R.-P.: Physicochemical, crystallographic, thermal, and spectroscopic behavior of crystalline and X-ray amorphous ciclesonide. J. Pharm. Sci. 97(9), 3765\u20133780 (2008)","journal-title":"J. Pharm. Sci."},{"key":"416_CR38","author":"TC Carvalho","year":"2011","unstructured":"Carvalho, T.C., Peters, J.I., Williams III, R.O.: Influence of particle size on regional lung deposition\u2014what evidence is there? Int. J. Pharm. (2011). doi: 10.1016\/j.ijpharm.2010.12.040","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Inclusion Phenomena and Macrocyclic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10847-014-0416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10847-014-0416-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10847-014-0416-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:30:54Z","timestamp":1559269854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10847-014-0416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,30]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s10847-014-0416-4","relation":{},"ISSN":["1388-3127","1573-1111"],"issn-type":[{"value":"1388-3127","type":"print"},{"value":"1573-1111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,30]]}}}